AGEN
NASDAQ · Biotechnology
Agenus Inc
$7.01
+0.11 (+1.59%)
Open$6.85
Previous Close$6.90
Day High$7.03
Day Low$6.71
52W High$8.85
52W Low$2.71
Volume—
Avg Volume1.54M
Market Cap315.14M
P/E Ratio4.88
EPS$1.67
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+443.9% upside
Current
$7.01
$7.01
Target
$38.13
$38.13
$23.34
$38.13 avg
$40.06
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 172.66M | 164.09M | 22.23M |
| Net Income | 175.3K | 150.0K | -3,026,461 |
| Profit Margin | 0.1% | 0.1% | -13.6% |
| EBITDA | 136.91M | 123.62M | -4,014,681 |
| Free Cash Flow | — | — | -2,971,274 |
| Rev Growth | +5.2% | +5.2% | +14.5% |
| Debt/Equity | 0.41 | 0.41 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |